Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors »

Crispr Therapeutics shares owned by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors from 13F filings

Historical chart of Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $285k 4.2k 68.16
2023-12-31 $309k 4.9k 62.59
2023-09-30 $312k 6.9k 45.39
2023-06-30 $393k 7.0k 56.14
2023-03-31 $312k 7.1k 44.16
2022-12-31 $292k 7.2k 40.65
2022-09-30 $482k 7.4k 65.40
2022-06-30 $553k 7.4k 75.03
2022-03-31 $362k 5.8k 62.74
2021-12-31 $400k 5.3k 75.87
2021-09-30 $444k 4.0k 111.81
2021-06-30 $647k 4.0k 161.79
2021-03-31 $487k 4.0k 121.78
2020-12-31 $393k 2.6k 152.92
2020-09-30 $317k 3.8k 83.53
2020-06-30 $224k 3.1k 73.44
2019-12-31 $231k 4.0k 58.48
2019-09-30 $203k 5.0k 41.01
2019-06-30 $233k 5.0k 47.07
2019-03-31 $206k 5.9k 34.92